Neurogene (NGNE) Return on Capital Employed (QoQ) (2014 - 2026)
Neurogene (NGNE) Return on Capital Employed (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -508.00 |
| Dec 31, 2025 | -299.00 |
| Sep 30, 2025 | -212.00 |
| Jun 30, 2025 | -408.00 |
| Mar 31, 2025 | 637.00 |
| Dec 31, 2024 | 1,337.00 |
| Sep 30, 2024 | -909.00 |
| Jun 30, 2024 | -835.00 |
| Mar 31, 2024 | 1,065.00 |
| Dec 31, 2023 | 1,890.00 |
| Sep 30, 2023 | -493.00 |
| Jun 30, 2023 | 30.00 |
| Mar 31, 2023 | -524.00 |
| Dec 31, 2022 | -142.00 |
| Sep 30, 2022 | -314.00 |
| Jun 30, 2022 | -511.00 |
| Mar 31, 2022 | -342.00 |
| Dec 31, 2021 | -399.00 |
| Sep 30, 2021 | -955.00 |
| Jun 30, 2021 | -406.00 |